RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Accel Wealth Management's Holding History (CIK: 0001838226)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 40,200 Value ($000) $164 Avg Close $4.95 Range $3.81 - $7.18

Q3 2025

Shares 44,200 Value ($000) $216 Avg Close $5.25 Range $4.45 - $7.15

Q2 2025

Shares 44,200 Value ($000) $224 Avg Close $4.91 Range $3.79 - $6.11

Q1 2025

Shares 44,050 Value ($000) $233 Avg Close $7.29 Range $5.19 - $12.36

Q4 2024

Shares 45,800 Value ($000) $310 Avg Close $6.72 Range $5.60 - $9.55

Q2 2023

Shares 10,330 Value ($000) $77 Avg Close $7.00 Range $4.54 - $10.45

Q1 2023

Shares 6,100 Value ($000) $41 Avg Close $7.93 Range $6.40 - $9.73

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	40,200	$164	$4.95	$3.81 - $7.18
Q3 2025	44,200	$216	$5.25	$4.45 - $7.15
Q2 2025	44,200	$224	$4.91	$3.79 - $6.11
Q1 2025	44,050	$233	$7.29	$5.19 - $12.36
Q4 2024	45,800	$310	$6.72	$5.60 - $9.55
Q2 2023	10,330	$77	$7.00	$4.54 - $10.45
Q1 2023	6,100	$41	$7.93	$6.40 - $9.73